showed that upregulation of m5C-modified LRRC8A promoted cervical cancer tumorigenesis and elucidated the NSUN2-m5C-LRRC8A axis as a potential therapeutic target in cervical cancer, providing strong evidence to support our study. This evidence concerns the gene NSUN2 and cervical carcinoma.